Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Post-operative minimal residual disease models to study metastatic relapse in soft-tissue sarcoma patient-derived xenografts.
Clin Transl Med. 2023 Jun;13(6):e1290. doi: 10.1002/ctm2.1290.
Clin Transl Med. 2023.
PMID: 37282823
Free PMC article.
No abstract available.
Targeted AURKA degradation: Towards new therapeutic agents for neuroblastoma.
Rishfi M, Krols S, Martens F, Bekaert SL, Sanders E, Eggermont A, De Vloed F, Goulding JR, Risseeuw M, Molenaar J, De Wilde B, Van Calenbergh S, Durinck K.
Rishfi M, et al. Among authors: bekaert sl.
Eur J Med Chem. 2023 Feb 5;247:115033. doi: 10.1016/j.ejmech.2022.115033. Epub 2022 Dec 18.
Eur J Med Chem. 2023.
PMID: 36549117
Item in Clipboard
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry.
Decaesteker B, Louwagie A, Loontiens S, De Vloed F, Bekaert SL, Roels J, Vanhauwaert S, De Brouwer S, Sanders E, Berezovskaya A, Denecker G, D'haene E, Van Haver S, Van Loocke W, Van Dorpe J, Creytens D, Van Roy N, Pieters T, Van Neste C, Fischer M, Van Vlierberghe P, Roberts SS, Schulte J, Ek S, Versteeg R, Koster J, van Nes J, Zimmerman M, De Preter K, Speleman F.
Decaesteker B, et al. Among authors: bekaert sl.
Nat Commun. 2023 Mar 7;14(1):1267. doi: 10.1038/s41467-023-36735-2.
Nat Commun. 2023.
PMID: 36882421
Free PMC article.
Item in Clipboard
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.
Nunes C, Depestel L, Mus L, Keller KM, Delhaye L, Louwagie A, Rishfi M, Whale A, Kara N, Andrews SR, Dela Cruz F, You D, Siddiquee A, Cologna CT, De Craemer S, Dolman E, Bartenhagen C, De Vloed F, Sanders E, Eggermont A, Bekaert SL, Van Loocke W, Bek JW, Dewyn G, Loontiens S, Van Isterdael G, Decaesteker B, Tilleman L, Van Nieuwerburgh F, Vermeirssen V, Van Neste C, Ghesquiere B, Goossens S, Eyckerman S, De Preter K, Fischer M, Houseley J, Molenaar J, De Wilde B, Roberts SS, Durinck K, Speleman F.
Nunes C, et al. Among authors: bekaert sl.
Sci Adv. 2022 Jul 15;8(28):eabn1382. doi: 10.1126/sciadv.abn1382. Epub 2022 Jul 13.
Sci Adv. 2022.
PMID: 35857500
Free PMC article.
Item in Clipboard
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN.
Gabre JL, Merseburger P, Claeys A, Siaw J, Bekaert SL, Speleman F, Hallberg B, Palmer RH, Van den Eynden J.
Gabre JL, et al. Among authors: bekaert sl.
NAR Cancer. 2024 Jan 11;6(1):zcad062. doi: 10.1093/narcan/zcad062. eCollection 2024 Mar.
NAR Cancer. 2024.
PMID: 38213997
Free PMC article.
Item in Clipboard
Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma.
Van Haver S, Fan Y, Bekaert SL, Everaert C, Van Loocke W, Zanzani V, Deschildre J, Maestre IF, Amaro A, Vermeirssen V, De Preter K, Zhou T, Kentsis A, Studer L, Speleman F, Roberts SS.
Van Haver S, et al. Among authors: bekaert sl.
iScience. 2023 Sep 30;27(1):108096. doi: 10.1016/j.isci.2023.108096. eCollection 2024 Jan 19.
iScience. 2023.
PMID: 38222111
Free PMC article.
Item in Clipboard
Cite
Cite